Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Role of medical history in brain tumour development. Results from the international adult brain tumour study

Identifieur interne : 00C644 ( Main/Exploration ); précédent : 00C643; suivant : 00C645

Role of medical history in brain tumour development. Results from the international adult brain tumour study

Auteurs : B. Schlehofer [Allemagne] ; M. Blettner [Allemagne] ; S. Preston-Martin [États-Unis] ; D. Niehoff [Allemagne] ; J. Wahrendorf [Allemagne] ; A. Arslan [Allemagne] ; A. Ahlbom [Suède] ; W. N. Choi ; G. G. Giles [Australie] ; G. R. Howe [États-Unis] ; J. Little [Royaume-Uni] ; F. Menegoz [France] ; P. Ryan [Australie]

Source :

RBID : Pascal:99-0375688

Descripteurs français

English descriptors

Abstract

In an international population-based case-control study carried out in 8 centres in 6 countries, we investigated the role of specific medical conditions in the aetiology of brain tumours in adults. Recruited were 1,178 glioma and 331 meningioma cases and 2,493 age- and gender-matched population controls. Only medical conditions occurring at least 2 years before brain tumour diagnosis were considered. Relative risks (RRs) and 95% confidence intervals (Cls) were estimated using a conditional logistic regression model. Heterogeneity between centres was tested. No association between meningioma and previous medical conditions was observed. For glioma, there was an increased risk associated with epilepsy (RR = 6.55, 95% Cl 3,40-12.63), but this was considerably weaker for epilepsy of more than 20 years duration. The risk remained elevated after adjustment for use of anti-epileptic drugs. There was a statistically significant inverse association between glioma and all allergic diseases combined (RR = 0.59, 95% Cl 0.49-0.71); this was also observed for specific allergic conditions, namely, asthma and eczema. Subjects who reported a history of infectious diseases (e.g., colds, flu) showed a 30% reduction in risk (RR = 0.72, 95% Cl 0.61-0.85). The decreased risks for glioma in subjects reporting a history of allergic conditions or infectious diseases may indicate an influence of immunological factors on the development of glioma. The association between glioma and epilepsy has to be interpreted cautiously and needs further investigation.


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Role of medical history in brain tumour development. Results from the international adult brain tumour study</title>
<author>
<name sortKey="Schlehofer, B" sort="Schlehofer, B" uniqKey="Schlehofer B" first="B." last="Schlehofer">B. Schlehofer</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blettner, M" sort="Blettner, M" uniqKey="Blettner M" first="M." last="Blettner">M. Blettner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Epidemiology and Medical Statistics, School of Public Health, University of Bielefeld</s1>
<s2>Bielefeld</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Bielefeld</wicri:noRegion>
<wicri:noRegion>University of Bielefeld</wicri:noRegion>
<wicri:noRegion>Bielefeld</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Preston Martin, S" sort="Preston Martin, S" uniqKey="Preston Martin S" first="S." last="Preston-Martin">S. Preston-Martin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>University of Southern California School of Medicine</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>University of Southern California School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Niehoff, D" sort="Niehoff, D" uniqKey="Niehoff D" first="D." last="Niehoff">D. Niehoff</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wahrendorf, J" sort="Wahrendorf, J" uniqKey="Wahrendorf J" first="J." last="Wahrendorf">J. Wahrendorf</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arslan, A" sort="Arslan, A" uniqKey="Arslan A" first="A." last="Arslan">A. Arslan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Epidemiology and Medical Statistics, School of Public Health, University of Bielefeld</s1>
<s2>Bielefeld</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Bielefeld</wicri:noRegion>
<wicri:noRegion>University of Bielefeld</wicri:noRegion>
<wicri:noRegion>Bielefeld</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ahlbom, A" sort="Ahlbom, A" uniqKey="Ahlbom A" first="A." last="Ahlbom">A. Ahlbom</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Division of Epidemiology, Institute for Environmental Medicine</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Suède</country>
<placeName>
<settlement type="city">Stockholm</settlement>
<region nuts="2">Svealand</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Choi, W N" sort="Choi, W N" uniqKey="Choi W" first="W. N." last="Choi">W. N. Choi</name>
</author>
<author>
<name sortKey="Giles, G G" sort="Giles, G G" uniqKey="Giles G" first="G. G." last="Giles">G. G. Giles</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Anti Cancer Council of Victoria</s1>
<s2>Victoria</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Anti Cancer Council of Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Howe, G R" sort="Howe, G R" uniqKey="Howe G" first="G. R." last="Howe">G. R. Howe</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Division of Epidemiology, Columbia University School of Public Health</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Little, J" sort="Little, J" uniqKey="Little J" first="J." last="Little">J. Little</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill</s1>
<s2>Aberdeen</s2>
<s3>GBR</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Aberdeen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Menegoz, F" sort="Menegoz, F" uniqKey="Menegoz F" first="F." last="Menegoz">F. Menegoz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Registre du Cancer du Department de l'Isère</s1>
<s2>Meylan</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Meylan</wicri:noRegion>
<wicri:noRegion>Registre du Cancer du Department de l'Isère</wicri:noRegion>
<wicri:noRegion>Registre du Cancer du Department de l'Isère</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ryan, P" sort="Ryan, P" uniqKey="Ryan P" first="P." last="Ryan">P. Ryan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Department of Public Health, University of Adelaide</s1>
<s2>Adelaide</s2>
<s3>AUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">99-0375688</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0375688 INIST</idno>
<idno type="RBID">Pascal:99-0375688</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">006300</idno>
<idno type="wicri:Area/PascalFrancis/Curation">006D54</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">005F14</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">005F14</idno>
<idno type="wicri:doubleKey">0020-7136:1999:Schlehofer B:role:of:medical</idno>
<idno type="wicri:Area/Main/Merge">00D627</idno>
<idno type="wicri:Area/Main/Curation">00C644</idno>
<idno type="wicri:Area/Main/Exploration">00C644</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Role of medical history in brain tumour development. Results from the international adult brain tumour study</title>
<author>
<name sortKey="Schlehofer, B" sort="Schlehofer, B" uniqKey="Schlehofer B" first="B." last="Schlehofer">B. Schlehofer</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Blettner, M" sort="Blettner, M" uniqKey="Blettner M" first="M." last="Blettner">M. Blettner</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Epidemiology and Medical Statistics, School of Public Health, University of Bielefeld</s1>
<s2>Bielefeld</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Bielefeld</wicri:noRegion>
<wicri:noRegion>University of Bielefeld</wicri:noRegion>
<wicri:noRegion>Bielefeld</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Preston Martin, S" sort="Preston Martin, S" uniqKey="Preston Martin S" first="S." last="Preston-Martin">S. Preston-Martin</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>University of Southern California School of Medicine</s1>
<s2>Los Angeles, CA</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>University of Southern California School of Medicine</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Niehoff, D" sort="Niehoff, D" uniqKey="Niehoff D" first="D." last="Niehoff">D. Niehoff</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wahrendorf, J" sort="Wahrendorf, J" uniqKey="Wahrendorf J" first="J." last="Wahrendorf">J. Wahrendorf</name>
<affiliation wicri:level="3">
<inist:fA14 i1="01">
<s1>German Cancer Research Centre, Division of Epidemiology</s1>
<s2>Heidelberg</s2>
<s3>DEU</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Karlsruhe</region>
<settlement type="city">Heidelberg</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Arslan, A" sort="Arslan, A" uniqKey="Arslan A" first="A." last="Arslan">A. Arslan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Department of Epidemiology and Medical Statistics, School of Public Health, University of Bielefeld</s1>
<s2>Bielefeld</s2>
<s3>DEU</s3>
<sZ>2 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
<wicri:noRegion>Bielefeld</wicri:noRegion>
<wicri:noRegion>University of Bielefeld</wicri:noRegion>
<wicri:noRegion>Bielefeld</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ahlbom, A" sort="Ahlbom, A" uniqKey="Ahlbom A" first="A." last="Ahlbom">A. Ahlbom</name>
<affiliation wicri:level="3">
<inist:fA14 i1="04">
<s1>Division of Epidemiology, Institute for Environmental Medicine</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Suède</country>
<placeName>
<settlement type="city">Stockholm</settlement>
<region nuts="2">Svealand</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Choi, W N" sort="Choi, W N" uniqKey="Choi W" first="W. N." last="Choi">W. N. Choi</name>
</author>
<author>
<name sortKey="Giles, G G" sort="Giles, G G" uniqKey="Giles G" first="G. G." last="Giles">G. G. Giles</name>
<affiliation wicri:level="1">
<inist:fA14 i1="05">
<s1>Anti Cancer Council of Victoria</s1>
<s2>Victoria</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Anti Cancer Council of Victoria</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Howe, G R" sort="Howe, G R" uniqKey="Howe G" first="G. R." last="Howe">G. R. Howe</name>
<affiliation wicri:level="1">
<inist:fA14 i1="06">
<s1>Division of Epidemiology, Columbia University School of Public Health</s1>
<s2>New York, NY</s2>
<s3>USA</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
<wicri:noRegion>New York, NY</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Little, J" sort="Little, J" uniqKey="Little J" first="J." last="Little">J. Little</name>
<affiliation wicri:level="1">
<inist:fA14 i1="07">
<s1>Department of Medicine and Therapeutics, University of Aberdeen Medical School, Foresterhill</s1>
<s2>Aberdeen</s2>
<s3>GBR</s3>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
<wicri:noRegion>Aberdeen</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Menegoz, F" sort="Menegoz, F" uniqKey="Menegoz F" first="F." last="Menegoz">F. Menegoz</name>
<affiliation wicri:level="1">
<inist:fA14 i1="08">
<s1>Registre du Cancer du Department de l'Isère</s1>
<s2>Meylan</s2>
<s3>FRA</s3>
<sZ>12 aut.</sZ>
</inist:fA14>
<country>France</country>
<wicri:noRegion>Meylan</wicri:noRegion>
<wicri:noRegion>Registre du Cancer du Department de l'Isère</wicri:noRegion>
<wicri:noRegion>Registre du Cancer du Department de l'Isère</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ryan, P" sort="Ryan, P" uniqKey="Ryan P" first="P." last="Ryan">P. Ryan</name>
<affiliation wicri:level="1">
<inist:fA14 i1="09">
<s1>Department of Public Health, University of Adelaide</s1>
<s2>Adelaide</s2>
<s3>AUS</s3>
<sZ>13 aut.</sZ>
</inist:fA14>
<country>Australie</country>
<wicri:noRegion>Adelaide</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">International journal of cancer</title>
<title level="j" type="abbreviated">Int. j. cancer</title>
<idno type="ISSN">0020-7136</idno>
<imprint>
<date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">International journal of cancer</title>
<title level="j" type="abbreviated">Int. j. cancer</title>
<idno type="ISSN">0020-7136</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Allergy</term>
<term>Antecedent</term>
<term>Anticonvulsant</term>
<term>Asthma</term>
<term>Case control study</term>
<term>Chemotherapy</term>
<term>Concomitant disease</term>
<term>Eczema</term>
<term>Epilepsy</term>
<term>Human</term>
<term>Intracranial</term>
<term>Malignant glioma</term>
<term>Malignant meningioma</term>
<term>Multicenter study</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Gliome malin</term>
<term>Intracrânien</term>
<term>Méningiome malin</term>
<term>Antécédent</term>
<term>Association morbide</term>
<term>Epilepsie</term>
<term>Chimiothérapie</term>
<term>Anticonvulsivant</term>
<term>Asthme</term>
<term>Allergie</term>
<term>Eczéma</term>
<term>Etude multicentrique</term>
<term>Etude cas témoin</term>
<term>Homme</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr">
<term>Allergie</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">In an international population-based case-control study carried out in 8 centres in 6 countries, we investigated the role of specific medical conditions in the aetiology of brain tumours in adults. Recruited were 1,178 glioma and 331 meningioma cases and 2,493 age- and gender-matched population controls. Only medical conditions occurring at least 2 years before brain tumour diagnosis were considered. Relative risks (RRs) and 95% confidence intervals (Cls) were estimated using a conditional logistic regression model. Heterogeneity between centres was tested. No association between meningioma and previous medical conditions was observed. For glioma, there was an increased risk associated with epilepsy (RR = 6.55, 95% Cl 3,40-12.63), but this was considerably weaker for epilepsy of more than 20 years duration. The risk remained elevated after adjustment for use of anti-epileptic drugs. There was a statistically significant inverse association between glioma and all allergic diseases combined (RR = 0.59, 95% Cl 0.49-0.71); this was also observed for specific allergic conditions, namely, asthma and eczema. Subjects who reported a history of infectious diseases (e.g., colds, flu) showed a 30% reduction in risk (RR = 0.72, 95% Cl 0.61-0.85). The decreased risks for glioma in subjects reporting a history of allergic conditions or infectious diseases may indicate an influence of immunological factors on the development of glioma. The association between glioma and epilepsy has to be interpreted cautiously and needs further investigation.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Australie</li>
<li>France</li>
<li>Royaume-Uni</li>
<li>Suède</li>
<li>États-Unis</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Karlsruhe</li>
<li>Svealand</li>
</region>
<settlement>
<li>Heidelberg</li>
<li>Stockholm</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Choi, W N" sort="Choi, W N" uniqKey="Choi W" first="W. N." last="Choi">W. N. Choi</name>
</noCountry>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Schlehofer, B" sort="Schlehofer, B" uniqKey="Schlehofer B" first="B." last="Schlehofer">B. Schlehofer</name>
</region>
<name sortKey="Arslan, A" sort="Arslan, A" uniqKey="Arslan A" first="A." last="Arslan">A. Arslan</name>
<name sortKey="Blettner, M" sort="Blettner, M" uniqKey="Blettner M" first="M." last="Blettner">M. Blettner</name>
<name sortKey="Niehoff, D" sort="Niehoff, D" uniqKey="Niehoff D" first="D." last="Niehoff">D. Niehoff</name>
<name sortKey="Wahrendorf, J" sort="Wahrendorf, J" uniqKey="Wahrendorf J" first="J." last="Wahrendorf">J. Wahrendorf</name>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Preston Martin, S" sort="Preston Martin, S" uniqKey="Preston Martin S" first="S." last="Preston-Martin">S. Preston-Martin</name>
</noRegion>
<name sortKey="Howe, G R" sort="Howe, G R" uniqKey="Howe G" first="G. R." last="Howe">G. R. Howe</name>
</country>
<country name="Suède">
<region name="Svealand">
<name sortKey="Ahlbom, A" sort="Ahlbom, A" uniqKey="Ahlbom A" first="A." last="Ahlbom">A. Ahlbom</name>
</region>
</country>
<country name="Australie">
<noRegion>
<name sortKey="Giles, G G" sort="Giles, G G" uniqKey="Giles G" first="G. G." last="Giles">G. G. Giles</name>
</noRegion>
<name sortKey="Ryan, P" sort="Ryan, P" uniqKey="Ryan P" first="P." last="Ryan">P. Ryan</name>
</country>
<country name="Royaume-Uni">
<noRegion>
<name sortKey="Little, J" sort="Little, J" uniqKey="Little J" first="J." last="Little">J. Little</name>
</noRegion>
</country>
<country name="France">
<noRegion>
<name sortKey="Menegoz, F" sort="Menegoz, F" uniqKey="Menegoz F" first="F." last="Menegoz">F. Menegoz</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00C644 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00C644 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     Pascal:99-0375688
   |texte=   Role of medical history in brain tumour development. Results from the international adult brain tumour study
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024